METHYL 2-(METHYLAMINO)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)NICOTINATE, 95%, 250mg

3,5-Dimethylisonicotinic acid, 95.0%, 1g

Oxazole, 4-(2-chlorophenyl)-, 95%, 100mg

(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate, 95.0%, 5g

Methylcyclopentadiene dimer, 1g

Bis(triphenylphosphine)palladium(II)diacetate, 95.0%, 1g

2-(2,5-Dimethylthiophen-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

4-Amino-3-nitropyridin-2(1H)-one, 95.0%, 1g

tert-Butyl 4-((4-hydroxypiperidin-1-yl)methyl)piperidine-1-carboxylate, 97%, 100mg

Diethyl (4-Cyanobenzyl)phosphonate>98.0%(GC)5g

tert-Butyl 2-(4-methoxyphenyl)-4-oxopiperidine-1-carboxylate, 97%, 250mg

Tetradecyl isobutyrate, 97.0%, 250mg

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-L-alaninamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg